Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

Sanofi plans to phase in its model for different 340B-eligible providers starting early next year. The rebates would apply to 25 drugs, including Dupixent, an injectable used to treat inflammatory ...

Sanofi joins Eli Lilly and Johnson & Johnson in seeking to change the 340B drug pricing program, facing pushback from HRSA and healthcare organizations.

In a letter sent to hospitals and clinics on Friday, Sanofi indicated that certain hospitals covered by the 340B Drug ...

Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.

President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...

Stocks rose to greet the week, which brings plenty of economic data, particularly in the U.S., as well as the latest Federal Reserve meeting minutes. Speeches from European Central Bank officials will ...

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be reconfigured within days during a pandemic—the drugmaker said it has ...

Sanofi SA added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to bolster preparedness for emergencies, including potential pandemics. The ...

Bristol Myers Squibb Co. is challenging a federal health agency for denying its plan to implement a rebate model for its ...